Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement
Open accessAbstract
Background and Aims: Coronavirus disease 2019 (COVID‐19), the illness caused by the SARS‐CoV‐2 virus, is rapidly spreading throughout the world. Hospitals and healthcare providers are preparing for the anticipated surge in critically ill patients, but few are wholly equipped to manage this new disease. The goals of this document are to provide data on what is currently known about COVID‐19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a template for the development of clinical recommendations and policies to mitigate the impact of the COVID‐19 pandemic on liver patients and healthcare providers. Approach and Results: This article discusses what is known about COVID‐19 with a focus on its impact on hepatologists, liver transplant providers, patients with liver disease, and liver transplant recipients. We provide clinicians with guidance for how to minimize the impact of the COVID‐19 pandemic on their patients’ care. Conclusions: The situation is evolving rapidly, and these recommendations will need to evolve as well. As we learn more about how the COVID‐19 pandemic impacts the care of patients with liver disease, we will update the online document available at https://www.aasld.org/about-aasld/covid-19-and-liver.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 46 · Cited by 473
Research works printed but not linked: 1
- Association of Organ Procurement Organizations. COVID-19 (coronavirus) bulletin. Published March 26, 2020. https://www.aopo.org/information-about-covid-19-coronavirus-is-being-released-rapidly- we-will-post-updates-as-we-receive-them. Accessed April 2020.
- Authors
- Fix, O. K., Hameed, B., Fontana, R. J., Kwok, R. M., McGuire, B. M., Mulligan, D. C., Pratt, D. S., Russo, M. W., Schilsky, M. L., Verna, E. C., Loomba, R., Cohen, D. E., Bezerra, J. A., Reddy, K. R., & Chung, R. T.
- Affiliations
- Swedish Medical Center (US)
- University of California, San Francisco (US)
- University of Michigan (US)
- Uniformed Services University of the Health Sciences (US)
- University of Alabama at Birmingham (US)
- Yale University (US)
- Massachusetts General Hospital (US)
- Carolinas Medical Center (US)
- Columbia University (US)
- University of California San Diego (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Fix, Oren K.
- Reddy, K. Rajender
- Chung, Raymond T.
- ORCID
- Venue
- Hepatology
- Published
- 2020-07
- Volume
- 72
- Issue
- 1
- Pages
- 287-304
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- PMC
- PMC7262242
- OpenAlex
- W3016474181
- Cited by
- 473
- References
- 46
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 27 · 2023: 51 · 2022: 77 · 2021: 155 · 2020: 152
- FWCI
- 39.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Hepatology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Department of Defense (5UL1TR001442, CA170674P2)
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Massachusetts General Hospital
- American Association for the Study of Liver Diseases
- Gilead Sciences
- University of Southern California
- Alnylam Pharmaceuticals
- Celgene
- University of Pennsylvania
- Northwestern University
- Cincinnati Children's Hospital Medical Center
- University of Minnesota
- Arrowhead Pharmaceuticals
- Grifols
- Esperion Therapeutics
- National Institutes of Health (UL1TR001442, UL1TR001863)
- Allergan
- University of North Carolina at Chapel Hill
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK121378, R01DK106419, P30DK120515)
- National Institute of Environmental Health Sciences (P42ES010337)
- National Center for Advancing Translational Sciences
- DOD Peer Reviewed Cancer Research Program
- Topics
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- COVID-19 pandemic, SARS-CoV-2, liver disease, liver transplantation, transplant recipients, clinical guidelines, infection control
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Drug Interactions, Gastroenterology, Humans, Immunosuppression Therapy, Internship and Residency, Liver Diseases, Pneumonia, Viral, Tissue Donors, Comorbidity, Liver Transplantation, Occupational Health, Practice Guidelines as Topic, Coronavirus Infections, Consensus, Pandemics, Patient Safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
